Trendlines says that the SEGER IDEA device enables surgeons to align, close, and staple the common enterotomy quickly and securely entirely inside the body, eliminating the need for complex hand-sewn suturing or the traditional "extracorporeal" method, which requires larger incisions and lifting the bowel outside the abdominal cavity.
The Trendlines Group (Trendlines) (SGX:42T
) announced that its portfolio company Seger Surgical Solutions Ltd (Seger) achieved the successful completion of three first-in-human cases in a clinical trial for its proprietary SEGER IDEA laparoscopic bowel closure device.
The above procedures were conducted at Zacamil National Hospital in El Salvador.
